https://medicaex.com/businesswire/exo-cfo-lori-munoz-wins-stevie-award-for-women-in-business/ 2022-11-22T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exo_Logo_Horizontal-ihCcBN.jpeg https://medicaex.com/businesswire/global-online-on-demand-home-services-market-to-reach-2-7-billion-by-2027-at-a-57-6-cagr-researchandmarkets-com-2/ 2022-11-22T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-FDALnk.jpeg https://medicaex.com/businesswire/cibc-innovation-banking-provides-25-million-in-debt-financing-to-podimetrics-inc/ 2022-11-22T14:12:07+00:00 https://medicaex.com/businesswire/masimo-to-present-in-piper-sandler-34th-annual-healthcare-conference/ 2022-11-22T14:12:07+00:00 https://medicaex.com/businesswire/fujifilm-invests-188-million-in-new-cell-culture-media-manufacturing-facility-2/ 2022-11-22T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/FUJIFILM_VFI_lores_282029-AuElwB.jpeg https://medicaex.com/businesswire/amylyx-pharmaceuticals-to-participate-in-the-evercore-isi-5th-annual-healthconx-conference/ 2022-11-22T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/13268_Amylyx_logo_notagline-Color-C5Xe4p.jpeg https://medicaex.com/businesswire/whats-next-for-world-hematology-and-flow-cytometry-analyzer-and-reagent-markets-2022-continued-advances-in-molecular-diagnostics-monoclonal-antibodies-lasers-and-it-drive-sector-researchandmark/ 2022-11-22T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mFCDE4.jpeg https://medicaex.com/businesswire/infinity-pharmaceuticals-to-participate-in-piper-sandler-34th-annual-healthcare-conference/ 2022-11-22T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/INFI_LOGO_TM_RGB-ogOind.jpeg https://medicaex.com/businesswire/blue-earth-diagnostics-highlights-presentations-on-axumin-fluciclovine-f-18-at-upcoming-rsna-2022-annual-meeting/ 2022-11-22T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/BED_Bracco_28RGB29-jtnSRb.jpeg https://medicaex.com/businesswire/fujifilm-invests-188-million-in-new-cell-culture-media-manufacturing-facility/ 2022-11-22T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/FUJIFILM_VFI_lores_282029-75hat0.jpeg https://medicaex.com/businesswire/new-survey-from-betterhelp-reveals-nearly-half-of-americans-are-worried-about-their-mental-health-this-holiday-season/ 2022-11-22T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/betterhelp-logo-w6zDI5.jpeg https://medicaex.com/businesswire/global-online-on-demand-home-services-market-to-reach-2-7-billion-by-2027-at-a-57-6-cagr-researchandmarkets-com/ 2022-11-22T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-S87D2X.jpeg https://medicaex.com/businesswire/lantern-pharma-announces-positive-data-highlighting-the-anti-tumor-potency-of-drug-candidate-lp-184-for-glioblastoma-at-the-society-for-neuro-oncology-annual-meeting-2/ 2022-11-22T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lantern_Logo_Stacked-98bS0P.jpeg https://medicaex.com/businesswire/mainstay-medical-announces-publication-of-post-market-clinical-trial-data-from-ongoing-reactiv8-c-study-in-chronic-low-back-pain-patients-2/ 2022-11-22T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Reactiv1-s9hx9A.jpeg https://medicaex.com/businesswire/ge-healthcare-imaging-solutions-increase-workflow-efficiency-and-optimize-radiologists-time-to-help-reduce-burnout-2/ 2022-11-22T13:12:15+00:00 https://medicaex.com/businesswire/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference-2/ 2022-11-22T13:12:15+00:00 https://medicaex.com/businesswire/immunoprecise-antibodies-ltd-announces-voluntary-delisting-from-tsx-venture-exchange-2/ 2022-11-22T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/IPA_Tagline_Gray_lg-RGB-5Wck9C.jpeg https://medicaex.com/businesswire/docgo-to-present-at-the-benchmark-companys-upcoming-discovery-one-on-one-investor-conference-2/ 2022-11-22T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-ZyPiPB.jpeg https://medicaex.com/businesswire/ge-healthcare-imaging-solutions-increase-workflow-efficiency-and-optimize-radiologists-time-to-help-reduce-burnout/ 2022-11-22T13:12:12+00:00 https://medicaex.com/businesswire/metagenomi-announces-participation-in-november-and-december-investor-conferences/ 2022-11-22T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Metagenomi-logo_RGB-R6PzzP.jpeg https://medicaex.com/businesswire/applied-uv-declares-monthly-preferred-stock-dividend-2/ 2022-11-22T13:12:12+00:00 https://medicaex.com/businesswire/generate-biomedicines-grows-leadership-team-with-head-of-vaccines-and-infectious-disease-research-and-senior-vice-president-of-technical-operations/ 2022-11-22T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/generate-bio-logo-rgb-black-zeUbQq.jpeg https://medicaex.com/businesswire/lensar-to-present-at-two-upcoming-investor-conferences/ 2022-11-22T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/LNSR_Logo-aoCUvb.jpeg https://medicaex.com/businesswire/applied-uv-declares-monthly-preferred-stock-dividend/ 2022-11-22T13:12:11+00:00 https://medicaex.com/businesswire/nextgen-healthcare-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-22T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/NG_Logo_Final_RGB_300-vgqGfl.jpeg https://medicaex.com/businesswire/mainstay-medical-announces-publication-of-post-market-clinical-trial-data-from-ongoing-reactiv8-c-study-in-chronic-low-back-pain-patients/ 2022-11-22T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Reactiv1-OZIGCs.jpeg https://medicaex.com/businesswire/dermavant-launches-first-commercial-for-vtama-tapinarof-cream-1-as-part-of-a-national-multimedia-campaign-for-adults-with-plaque-psoriasis/ 2022-11-22T13:12:09+00:00 https://medicaex.com/businesswire/immunoprecise-antibodies-ltd-announces-voluntary-delisting-from-tsx-venture-exchange/ 2022-11-22T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/IPA_Tagline_Gray_lg-RGB-h9XX74.jpeg https://medicaex.com/businesswire/lantern-pharma-announces-positive-data-highlighting-the-anti-tumor-potency-of-drug-candidate-lp-184-for-glioblastoma-at-the-society-for-neuro-oncology-annual-meeting/ 2022-11-22T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lantern_Logo_Stacked-kSkIbI.jpeg https://medicaex.com/businesswire/revance-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference/ 2022-11-22T13:12:08+00:00 https://medicaex.com/businesswire/vbi-vaccines-presents-additional-phase-1-2a-data-from-vbi-1901-in-recurrent-gbm-at-the-2022-society-for-neuro-oncology-sno-annual-meeting/ 2022-11-22T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-0VIjvn.jpeg https://medicaex.com/businesswire/docgo-to-present-at-the-benchmark-companys-upcoming-discovery-one-on-one-investor-conference/ 2022-11-22T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-aDpCG4.jpeg https://medicaex.com/businesswire/veterinary-telemedicine-company-dutch-launches-pet-insurance-in-partnership-with-pets-best/ 2022-11-22T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/dutchpetbestlogo-mvwbJJ.jpeg https://medicaex.com/businesswire/sage-therapeutics-and-biogen-to-host-investor-webcast-on-december-6-2022-to-discuss-potential-commercialization-plans-for-zuranolone-2/ 2022-11-22T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sage_Logo-MGZM8E.jpeg https://medicaex.com/businesswire/bicara-therapeutics-to-present-at-34th-annual-piper-sandler-healthcare-conference-2/ 2022-11-22T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bicara-HorizLogo-2Color-500px_28229-zsfJT6.jpeg https://medicaex.com/businesswire/enanta-pharmaceuticals-to-participate-in-two-investor-conferences-in-november-2/ 2022-11-22T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-7XWznF.jpeg https://medicaex.com/businesswire/worldwide-in-vitro-diagnostic-tests-market-report-2022-with-profiles-of-200-companies-financial-results-product-launches-company-history-and-strategic-plans-researchandmarkets-com/ 2022-11-22T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-2HBCXZ.jpeg https://medicaex.com/businesswire/astrazeneca-aims-to-redefine-breast-cancer-care-with-new-data-across-the-treatment-spectrum-at-sabcs-2022-2/ 2022-11-22T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-0h8ECA.jpeg https://medicaex.com/businesswire/vapotherm-announces-amendment-to-debt-agreement/ 2022-11-22T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/VAPO_Logo-Fd9Nsm.jpeg https://medicaex.com/businesswire/enanta-pharmaceuticals-to-participate-in-two-investor-conferences-in-november/ 2022-11-22T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-PWcncl.jpeg https://medicaex.com/businesswire/merck-announces-phase-3-keynote-859-trial-met-primary-endpoint-of-overall-survival-in-patients-with-her2-negative-gastric-or-gastroesophageal-junction-gej-adenocarcinoma/ 2022-11-22T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Merck_Logo_Horizontal_Teal26Grey_RGB-QZ5eWw.jpeg https://medicaex.com/businesswire/astrazeneca-aims-to-redefine-breast-cancer-care-with-new-data-across-the-treatment-spectrum-at-sabcs-2022/ 2022-11-22T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-SSJbuy.jpeg https://medicaex.com/businesswire/sage-therapeutics-and-biogen-to-host-investor-webcast-on-december-6-2022-to-discuss-potential-commercialization-plans-for-zuranolone/ 2022-11-22T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sage_Logo-CGQ9Vm.jpeg https://medicaex.com/businesswire/bicara-therapeutics-to-present-at-34th-annual-piper-sandler-healthcare-conference/ 2022-11-22T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bicara-HorizLogo-2Color-500px_28229-9GExai.jpeg https://medicaex.com/businesswire/openfold-ai-research-consortium-welcomes-4-new-members-bayer-dassault-charm-therapeutics-and-basecamp-research-2/ 2022-11-22T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/open_molecular_logo-fzO2aM.jpeg https://medicaex.com/businesswire/insulet-to-present-at-upcoming-investor-conferences-4/ 2022-11-22T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Insulet_Logo-rraPCy.jpeg https://medicaex.com/businesswire/alzheon-to-present-industry-leading-biomarker-brain-preservation-and-clinical-effects-with-oral-alz-801-valiltramiprosate-at-15th-annual-clinical-trials-in-alzheimers-disease-conference-2/ 2022-11-22T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/alzheon_logo-fb-UXB1Eu.jpeg https://medicaex.com/businesswire/the-worldwide-biologics-contract-development-manufacturing-organization-industry-is-projected-to-reach-12-5-billion-by-2027-at-a-12-23-cagr-researchandmarkets-com/ 2022-11-22T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oApT3H.jpeg https://medicaex.com/businesswire/janux-therapeutics-to-present-at-upcoming-investor-conferences-in-november-2/ 2022-11-22T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/janux-logo-web_page_01-FGe4bM.jpeg https://medicaex.com/businesswire/insulet-to-present-at-upcoming-investor-conferences-3/ 2022-11-22T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Insulet_Logo-VpNhnO.jpeg https://medicaex.com/businesswire/insulet-to-present-at-upcoming-investor-conferences-2/ 2022-11-22T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Insulet_Logo-rOKde1.jpeg https://medicaex.com/businesswire/insulet-to-present-at-upcoming-investor-conferences/ 2022-11-22T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Insulet_Logo-F2PaaS.jpeg https://medicaex.com/businesswire/alzheon-to-present-industry-leading-biomarker-brain-preservation-and-clinical-effects-with-oral-alz-801-valiltramiprosate-at-15th-annual-clinical-trials-in-alzheimers-disease-conference/ 2022-11-22T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/alzheon_logo-fb-JGK0UE.jpeg https://medicaex.com/businesswire/the-worldwide-pressure-ulcers-industry-is-projected-to-reach-5-6-billion-by-2031-researchandmarkets-com/ 2022-11-22T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mBjfcX.jpeg https://medicaex.com/businesswire/openfold-ai-research-consortium-welcomes-4-new-members-bayer-dassault-charm-therapeutics-and-basecamp-research/ 2022-11-22T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/open_molecular_logo-x9qecy.jpeg https://medicaex.com/businesswire/global-diabetic-retinopathy-market-report-to-2027-featuring-bayer-alimera-sciences-novartis-and-pfizer-among-others-researchandmarkets-com/ 2022-11-22T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-I8B3tq.jpeg https://medicaex.com/businesswire/janux-therapeutics-to-present-at-upcoming-investor-conferences-in-november/ 2022-11-22T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/janux-logo-web_page_01-I3puin.jpeg https://medicaex.com/businesswire/catalym-closes-eur-50-million-series-c-financing-to-expand-and-accelerate-phase-2-clinical-development-of-visugromab-in-patients-with-solid-tumors/ 2022-11-22T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-zpAk9u.jpeg https://medicaex.com/businesswire/turbine-raises-e20-million-in-series-a-financing-to-advance-programs-partnerships-towards-the-clinic-with-worlds-first-cancer-cell-simulation-platform-2/ 2022-11-22T07:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Turbine_logo-07-jflv8k.jpeg https://medicaex.com/businesswire/sense-and-r-biopharm-nederland-b-v-agree-to-distribute-rapid-instrument-free-molecular-covid-19-test-in-the-netherlands-belgium-and-luxembourg-3/ 2022-11-22T07:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sense_logo-K6MuYn.jpeg https://medicaex.com/businesswire/sense-and-r-biopharm-nederland-b-v-agree-to-distribute-rapid-instrument-free-molecular-covid-19-test-in-the-netherlands-belgium-and-luxembourg-2/ 2022-11-22T07:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sense_logo-50MWy4.jpeg https://medicaex.com/businesswire/turbine-raises-e20-million-in-series-a-financing-to-advance-programs-partnerships-towards-the-clinic-with-worlds-first-cancer-cell-simulation-platform/ 2022-11-22T07:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Turbine_logo-07-a7bTTt.jpeg https://medicaex.com/businesswire/sense-and-r-biopharm-nederland-b-v-agree-to-distribute-rapid-instrument-free-molecular-covid-19-test-in-the-netherlands-belgium-and-luxembourg/ 2022-11-22T07:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sense_logo-3g2crj.jpeg https://medicaex.com/businesswire/innocare-announces-approval-of-hibruka-orelabrutinib-for-the-treatment-of-mantle-cell-lymphoma-in-singapore-2/ 2022-11-22T06:14:43+00:00 https://medicaex.com/businesswire/innocare-announces-approval-of-hibruka-orelabrutinib-for-the-treatment-of-mantle-cell-lymphoma-in-singapore/ 2022-11-22T06:12:03+00:00 https://medicaex.com/businesswire/alcon-completes-acquisition-of-aerie-pharmaceuticals-inc-strengthening-companys-ophthalmic-pharmaceutical-business/ 2022-11-22T06:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alcon_CMYK_Tag-oX5nFB.jpeg https://medicaex.com/businesswire/gamida-cell-provides-regulatory-update-on-omidubicel-2/ 2022-11-21T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-J3G0Nr.jpeg https://medicaex.com/businesswire/invacare-appoints-geoff-purtill-president-and-chief-executive-officer/ 2022-11-21T22:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Invacare_Logo-C9XWD2.jpeg https://medicaex.com/businesswire/cutera-inc-to-participate-in-a-fireside-chat-at-the-34th-annual-piper-sandler-healthcare-conference/ 2022-11-21T22:12:05+00:00 https://medicaex.com/businesswire/gamida-cell-provides-regulatory-update-on-omidubicel/ 2022-11-21T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gamida-Cell-Logo_Sept2022-2OV7Q2.jpeg https://medicaex.com/businesswire/amber-specialty-pharmacy-selected-to-dispense-tzield-teplizumab-a-monoclonal-antibody-treatment-to-delay-onset-of-stage-3-type-1-diabetes-in-patients-ages-8-years-and-older-with-stage-2-ty/ 2022-11-21T22:12:04+00:00 https://medicaex.com/businesswire/biodesix-announces-closing-of-upsized-public-offering-and-full-exercise-of-option-to-purchase-additional-shares/ 2022-11-21T21:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biodesix_Logo-XWmQcn.jpeg https://medicaex.com/businesswire/prothena-announces-achievement-of-40-million-clinical-milestone-payment-from-novo-nordisk-for-prx004-nnc6019-under-investigation-for-the-treatment-of-attr-cardiomyopathy-2/ 2022-11-21T21:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/prothena_logo_rgb-VovfyC.jpeg https://medicaex.com/businesswire/biocept-reports-third-quarter-2022-financial-results-2/ 2022-11-21T21:12:15+00:00 https://medicaex.com/businesswire/qiagen-launches-monkeypox-test-for-neumodx-platform-to-fight-global-outbreak-by-boosting-research-and-surveillance-4/ 2022-11-21T21:12:15+00:00 https://medicaex.com/businesswire/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-fourth-quarter-and-year-ended-september-30-2022-with-webcast-and-conference-call-today-at-430-p-m-et-2/ 2022-11-21T21:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-L0RRt6.jpeg https://medicaex.com/businesswire/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference-2/ 2022-11-21T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/UroGen_logo2_28R29-lqXipH.jpeg https://medicaex.com/businesswire/qiagen-launches-monkeypox-test-for-neumodx-platform-to-fight-global-outbreak-by-boosting-research-and-surveillance-3/ 2022-11-21T21:12:09+00:00 https://medicaex.com/businesswire/agilent-reports-fourth-quarter-and-fiscal-year-2022-financial-results/ 2022-11-21T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Agilent-KClU9b.jpeg https://medicaex.com/businesswire/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference/ 2022-11-21T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/UroGen_logo2_28R29-6Qjyf2.jpeg https://medicaex.com/businesswire/biocept-reports-third-quarter-2022-financial-results/ 2022-11-21T21:12:05+00:00 https://medicaex.com/businesswire/qiagen-launches-monkeypox-test-for-neumodx-platform-to-fight-global-outbreak-by-boosting-research-and-surveillance-2/ 2022-11-21T21:12:05+00:00 https://medicaex.com/businesswire/enanta-pharmaceuticals-reports-financial-results-for-its-fiscal-fourth-quarter-and-year-ended-september-30-2022-with-webcast-and-conference-call-today-at-430-p-m-et/ 2022-11-21T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enanta_RGB-vINxK4.jpeg https://medicaex.com/businesswire/personalis-to-present-at-the-34th-annual-piper-sandler-healthcare-conference/ 2022-11-21T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-YgPzlN.jpeg https://medicaex.com/businesswire/prothena-announces-achievement-of-40-million-clinical-milestone-payment-from-novo-nordisk-for-prx004-nnc6019-under-investigation-for-the-treatment-of-attr-cardiomyopathy/ 2022-11-21T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/prothena_logo_rgb-UymNvE.jpeg https://medicaex.com/businesswire/qiagen-launches-monkeypox-test-for-neumodx-platform-to-fight-global-outbreak-by-boosting-research-and-surveillance/ 2022-11-21T21:12:03+00:00 https://medicaex.com/businesswire/alwyn-van-heerden-joins-multiplan-as-vice-president-of-strategy-and-corporate-development/ 2022-11-21T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/MULTIPLAN_LOGO_RGB_300dpi-nHm78I.jpeg https://medicaex.com/businesswire/uw-madison-to-perform-the-first-u-s-evaluation-of-ge-healthcares-photon-counting-ct-technology-with-deep-silicon-detectors/ 2022-11-21T19:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Logo-16TSID.jpeg https://medicaex.com/businesswire/global-personal-lubricant-market-report-2022-rising-acceptance-in-women-presents-opportunities-researchandmarkets-com-3/ 2022-11-21T18:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-X1pFik.jpeg https://medicaex.com/businesswire/tebra-cto-kyle-ryan-named-to-the-healthcare-technology-reports-list-of-top-healthcare-technology-ctos-of-2022/ 2022-11-21T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tebra_-_primary_logo_-_growth_-_RGB-aZyTM8.jpeg https://medicaex.com/businesswire/global-magnetic-resonance-imaging-market-report-to-2030-players-include-siemens-healthineers-general-electric-koninklijke-philips-and-bruker-researchandmarkets-com/ 2022-11-21T18:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-wtAaMo.jpeg https://medicaex.com/businesswire/global-personal-lubricant-market-report-2022-rising-acceptance-in-women-presents-opportunities-researchandmarkets-com-2/ 2022-11-21T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jHqQg2.jpeg https://medicaex.com/businesswire/global-personal-lubricant-market-report-2022-rising-acceptance-in-women-presents-opportunities-researchandmarkets-com/ 2022-11-21T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-zvbN8y.jpeg https://medicaex.com/businesswire/rubiconmd-appoints-new-chief-medical-officer-dr-laolu-fayanju-md/ 2022-11-21T18:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/RMD_Logo_Red_RGB_28429-MyNpQg.jpeg https://medicaex.com/businesswire/global-laboratory-balances-and-scales-market-report-to-2029-featuring-ad-company-metler-toleda-international-sartorius-and-adam-equipment-among-others-researchandmarkets-com/ 2022-11-21T17:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-5ImkSk.jpeg https://medicaex.com/businesswire/innovations-and-growth-opportunities-in-novel-diagnostics-and-monitoring-solutions-robotic-surgical-systems-ai-enabled-devices-researchandmarkets-com-3/ 2022-11-21T17:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-X7noQi.jpeg https://medicaex.com/businesswire/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience-2/ 2022-11-21T17:12:14+00:00 https://medicaex.com/businesswire/innovations-and-growth-opportunities-in-novel-diagnostics-and-monitoring-solutions-robotic-surgical-systems-ai-enabled-devices-researchandmarkets-com-2/ 2022-11-21T17:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-n5mue8.jpeg https://medicaex.com/businesswire/innovations-and-growth-opportunities-in-novel-diagnostics-and-monitoring-solutions-robotic-surgical-systems-ai-enabled-devices-researchandmarkets-com/ 2022-11-21T17:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-T1a5lm.jpeg https://medicaex.com/businesswire/millstone-medical-outsourcing-an-arlington-capital-partners-portfolio-company-acquires-mycoscience/ 2022-11-21T17:12:12+00:00 https://medicaex.com/businesswire/remote-medical-service-business-for-the-african-american-community-market-analysis-2022-continued-rise-of-telehealth-primes-market-for-new-entrants-researchandmarkets-com/ 2022-11-21T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RbBfOA.jpeg https://medicaex.com/businesswire/global-cryogenic-vials-market-2023-2027-increasing-adoption-of-cryopreservation-procedures-the-growing-use-of-cryogenic-vials-in-drug-rd-and-government-support-driving-growth-researchandmarke/ 2022-11-21T16:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-l37Bsb.jpeg https://medicaex.com/businesswire/divis-scalp-serum-named-best-scalp-treatment-of-2022-by-shape-beauty-awards/ 2022-11-21T16:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Divi_Logo-fL3dJN.jpeg https://medicaex.com/businesswire/pharmaessentia-to-host-investor-day-in-new-york-city-on-november-30-2022-2/ 2022-11-21T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pharma-essentia-m938C6.jpeg https://medicaex.com/businesswire/the-worldwide-mycoplasma-testing-industry-is-expected-to-reach-2-2-billion-by-2030-researchandmarkets-com-2/ 2022-11-21T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ALEKJj.jpeg https://medicaex.com/businesswire/blackford-and-equium-intelligence-announce-strategic-partnership/ 2022-11-21T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BlackfordAnalysisLogo-wmpZRB.jpeg https://medicaex.com/businesswire/simplify-healthcare-ranks-199-among-the-fastest-growing-companies-in-north-america-on-the-2022-deloitte-technology-fast-500/ 2022-11-21T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Simplify_Healthcare_Logo-6pgUSG.jpeg https://medicaex.com/businesswire/new-view-surgical-inc-closes-12-1m-series-b-1-financing-readies-limited-market-release-of-its-visionport-system-for-minimally-invasive-surgery/ 2022-11-21T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/nvs_logo-01-SgKKi1.jpeg https://medicaex.com/businesswire/new-view-surgical-inc-closes-12-1m-series-b-1-financing-readies-limited-market-release-of-its-visionport-system-for-minimally-invasive-surgery-2/ 2022-11-21T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/nvs_logo-01-3aVjA5.jpeg https://medicaex.com/businesswire/global-wearable-patch-market-report-to-2027-players-include-abbott-laboratories-delta-electronics-gentag-and-insulet-researchandmarkets-com/ 2022-11-21T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ba8FNN.jpeg https://medicaex.com/businesswire/the-worldwide-mycoplasma-testing-industry-is-expected-to-reach-2-2-billion-by-2030-researchandmarkets-com/ 2022-11-21T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-LAXUxD.jpeg https://medicaex.com/businesswire/global-influenza-diagnostics-market-report-2022-to-2030-increasing-prevalence-of-chronic-diseases-and-government-initiatives-to-counter-influenza-is-driving-growth-researchandmarkets-com/ 2022-11-21T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1eThwd.jpeg https://medicaex.com/businesswire/pharmaessentia-to-host-investor-day-in-new-york-city-on-november-30-2022/ 2022-11-21T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pharma-essentia-dbec4C.jpeg https://medicaex.com/businesswire/data-across-daiichi-sankyo-dxd-adc-portfolio-at-2022-sabcs-demonstrates-bold-progress-in-advancing-treatment-for-patients-with-breast-cancer/ 2022-11-21T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/DS_logo_portrait_format_4color_rgb_120206-V7hN1s.jpeg https://medicaex.com/businesswire/mms-named-michigan-top-workplace-for-the-second-consecutive-year-3/ 2022-11-21T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/MMS_logo_wTagline_white_background_8_24_17-MHZMjl.jpeg https://medicaex.com/businesswire/opna-bio-launches-with-38-million-series-a-financing-to-advance-novel-oncology-discovery-program-and-diversified-pipeline-of-clinical-and-preclinical-programs-2/ 2022-11-21T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gideon_Bollag2C_PhD2C_Opna_Bio_CEO-BGWY9F.jpeg https://medicaex.com/businesswire/scorpion-therapeutics-to-present-preclinical-data-for-potential-best-in-class-mutant-selective-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium-3/ 2022-11-21T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scorpion_Logo-5DO0xh.jpeg https://medicaex.com/businesswire/zymeworks-announces-abstract-for-zanidatamab-in-late-line-her2-positive-hormone-receptor-positive-hr-metastatic-breast-cancer-at-the-san-antonio-breast-cancer-symposium-sabcs-2/ 2022-11-21T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-BRmRFX.jpeg https://medicaex.com/businesswire/fitxr-turns-it-up-loud-with-new-music-collections-featuring-top-artists/ 2022-11-21T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/FitXR_logo-2sgXyf.jpeg https://medicaex.com/businesswire/leading-healthcare-organizations-choose-qualtrics-to-deliver-ease-and-empathy-to-patients-and-caregivers/ 2022-11-21T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/QualtricsXM_RBG-w0PjRg.jpeg https://medicaex.com/businesswire/schrodinger-to-present-at-piper-sandler-34th-annual-healthcare-conference/ 2022-11-21T14:12:09+00:00 https://medicaex.com/businesswire/swing-therapeutics-announces-positive-results-from-studies-of-stanza-a-digital-therapeutic-for-fibromyalgia-treatment-3/ 2022-11-21T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Swing_logo-ZKfdtm.jpeg https://medicaex.com/businesswire/scorpion-therapeutics-to-present-preclinical-data-for-potential-best-in-class-mutant-selective-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium-2/ 2022-11-21T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scorpion_Logo-rhMgdZ.jpeg https://medicaex.com/businesswire/mms-named-michigan-top-workplace-for-the-second-consecutive-year-2/ 2022-11-21T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/MMS_logo_wTagline_white_background_8_24_17-DN1wqb.jpeg https://medicaex.com/businesswire/swing-therapeutics-announces-positive-results-from-studies-of-stanza-a-digital-therapeutic-for-fibromyalgia-treatment-2/ 2022-11-21T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Swing_logo-wGfEup.jpeg https://medicaex.com/businesswire/medimaps-group-at-rsna-2022-providing-the-full-bone-health-picture/ 2022-11-21T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/MMlogo-ULvSiW.jpeg https://medicaex.com/businesswire/scorpion-therapeutics-to-present-preclinical-data-for-potential-best-in-class-mutant-selective-pi3k%ce%b1-inhibitor-at-san-antonio-breast-cancer-symposium/ 2022-11-21T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scorpion_Logo-rJWwxS.jpeg https://medicaex.com/businesswire/zymeworks-announces-abstract-for-zanidatamab-in-late-line-her2-positive-hormone-receptor-positive-hr-metastatic-breast-cancer-at-the-san-antonio-breast-cancer-symposium-sabcs/ 2022-11-21T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-U9Q0zk.jpeg https://medicaex.com/businesswire/swing-therapeutics-announces-positive-results-from-studies-of-stanza-a-digital-therapeutic-for-fibromyalgia-treatment/ 2022-11-21T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Swing_logo-kIw1V3.jpeg https://medicaex.com/businesswire/opna-bio-launches-with-38-million-series-a-financing-to-advance-novel-oncology-discovery-program-and-diversified-pipeline-of-clinical-and-preclinical-programs/ 2022-11-21T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gideon_Bollag2C_PhD2C_Opna_Bio_CEO-qf22In.jpeg https://medicaex.com/businesswire/mms-named-michigan-top-workplace-for-the-second-consecutive-year/ 2022-11-21T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/MMS_logo_wTagline_white_background_8_24_17-s0PUKp.jpeg https://medicaex.com/businesswire/pediatric-telehealth-market-report-2022-telehealth-shifting-toward-platform-as-a-service-researchandmarkets-com/ 2022-11-21T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-10tFFq.jpeg https://medicaex.com/businesswire/flare-therapeutics-to-present-at-piper-sandler-34th-annual-healthcare-conference-2/ 2022-11-21T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/FlareTx-Logo-OverLightBG-0omCgl.jpeg https://medicaex.com/businesswire/scientific-study-shows-virtual-reality-vr-use-improves-sperm-quality/ 2022-11-21T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/PNG_BLUE_RGB_Sperm_26_Egg_Bank_28529-xozorL.jpeg https://medicaex.com/businesswire/rocket-pharmaceuticals-to-present-at-the-5th-annual-evercore-isi-healthconx-conference-2/ 2022-11-21T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rocket_Pharma-UpJrQr.jpeg https://medicaex.com/businesswire/verge-genomics-to-present-at-upcoming-investor-conferences-in-november-3/ 2022-11-21T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Verge_Logo_28429-euirqs.jpeg https://medicaex.com/businesswire/graphite-bio-announces-participation-in-evercore-isi-5th-annual-healthconx-conference-2/ 2022-11-21T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Graphite_Bio_Primary_Logo_RGB_M01-SFh3o4.jpeg https://medicaex.com/businesswire/verge-genomics-to-present-at-upcoming-investor-conferences-in-november-2/ 2022-11-21T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Verge_Logo_28429-FBhpJ8.jpeg https://medicaex.com/businesswire/peer-reviewed-study-finds-that-masimo-set-pulse-oximetry-has-no-clinically-significant-difference-in-accuracy-or-bias-between-black-and-white-people-2/ 2022-11-21T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/SETPRimage_square-NYX1A6.jpeg https://medicaex.com/businesswire/cardio-diagnostics-to-present-at-the-benchmark-companys-upcoming-discovery-one-on-one-investor-conference/ 2022-11-21T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cardio_Diagnostics_Logo_1-16cdZa.jpeg https://medicaex.com/businesswire/peer-reviewed-study-finds-that-masimo-set-pulse-oximetry-has-no-clinically-significant-difference-in-accuracy-or-bias-between-black-and-white-people/ 2022-11-21T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/SETPRimage_square-WAdE9P.jpeg https://medicaex.com/businesswire/colonoscopy-devices-global-market-report-2022-featuring-boston-scientific-corporation-medtronic-steris-olympus-hoya-researchandmarkets-com/ 2022-11-21T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ehl6Gf.jpeg https://medicaex.com/businesswire/healiva-acquires-critical-cell-therapy-manufacturing-assets-from-b-braun/ 2022-11-21T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Healiva_logopng-jVrT1h.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-to-present-at-evercore-isi-healthconx-conference-2/ 2022-11-21T13:12:06+00:00 https://medicaex.com/businesswire/global-syphilis-testing-market-report-to-2028-increasing-government-funding-or-investments-on-std-testing-is-driving-growth-researchandmarkets-com-2/ 2022-11-21T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-oWY7ca.jpeg https://medicaex.com/businesswire/sightpath-medical-acquires-accusite-surgical/ 2022-11-21T13:12:05+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-to-present-at-evercore-isi-healthconx-conference/ 2022-11-21T13:12:05+00:00 https://medicaex.com/businesswire/verge-genomics-to-present-at-upcoming-investor-conferences-in-november/ 2022-11-21T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Verge_Logo_28429-GxQpUg.jpeg https://medicaex.com/businesswire/graphite-bio-announces-participation-in-evercore-isi-5th-annual-healthconx-conference/ 2022-11-21T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Graphite_Bio_Primary_Logo_RGB_M01-ZI8iSa.jpeg https://medicaex.com/businesswire/flare-therapeutics-to-present-at-piper-sandler-34th-annual-healthcare-conference/ 2022-11-21T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/FlareTx-Logo-OverLightBG-Bqe8v0.jpeg https://medicaex.com/businesswire/global-syphilis-testing-market-report-to-2028-increasing-government-funding-or-investments-on-std-testing-is-driving-growth-researchandmarkets-com/ 2022-11-21T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-U9BDgS.jpeg https://medicaex.com/businesswire/rocket-pharmaceuticals-to-present-at-the-5th-annual-evercore-isi-healthconx-conference/ 2022-11-21T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rocket_Pharma-HOCFhy.jpeg https://medicaex.com/businesswire/teva-announces-appointment-of-richard-francis-as-president-and-ceo-2/ 2022-11-21T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Teva_CEO_Infographic_External-cpDgU4.jpeg https://medicaex.com/businesswire/merck-kgaa-darmstadt-germany-aims-to-double-rd-productivity-in-oncology-neurology-and-immunology-to-deliver-more-medicines-to-patients-faster-2/ 2022-11-21T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-6lAgsL.jpeg https://medicaex.com/businesswire/merck-aims-to-double-rd-productivity-in-oncology-neurology-and-immunology-to-deliver-more-medicines-to-patients-faster-2/ 2022-11-21T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/11127HIGH_MERCKLOGOBLUERGB-PROIMG-XxOHeu.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order-4/ 2022-11-21T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO_28129-mMj6sQ.jpeg https://medicaex.com/businesswire/prominent-oncologist-to-discuss-advantages-of-oxford-biodynamics-episwitch-cirt-at-the-2022-liquid-biopsy-virtual-summit-2/ 2022-11-21T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/OBD_logo-skFJdS.jpeg https://medicaex.com/businesswire/koru-medical-systems-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference-2/ 2022-11-21T12:12:08+00:00 https://medicaex.com/businesswire/perkinelmer-helps-accelerate-gene-therapy-research-with-industry-first-ready-to-use-viral-vector-assays/ 2022-11-21T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/1200px-PerkinElmer_logo.svg-0m7xnS.jpeg https://medicaex.com/businesswire/endogastric-solutions-inc-develops-reflux-friendly-cookbook-to-promote-gerd-awareness-week/ 2022-11-21T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/EndoGastricSolutions-Logo-FullColor-TN0fE0.jpeg https://medicaex.com/businesswire/global-endoscope-reprocessing-market-2022-to-2027-high-risk-of-endoscope-associated-infections-is-driving-growth-researchandmarkets-com/ 2022-11-21T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-JZ3B4F.jpeg https://medicaex.com/businesswire/koru-medical-systems-to-participate-in-the-piper-sandler-34th-annual-healthcare-conference/ 2022-11-21T12:12:06+00:00 https://medicaex.com/businesswire/clinical-trial-supplies-global-market-report-2022-increasing-rd-expenditure-of-pharmaceutical-and-biotechnology-companies-to-drive-growth-researchandmarkets-com/ 2022-11-21T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KI1ZE8.jpeg https://medicaex.com/businesswire/rapid-dose-therapeutics-provides-update-on-failure-to-file-cease-trade-order-3/ 2022-11-21T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/RDT_LOGO_28129-yh3Gxx.jpeg https://medicaex.com/businesswire/prominent-oncologist-to-discuss-advantages-of-oxford-biodynamics-episwitch-cirt-at-the-2022-liquid-biopsy-virtual-summit/ 2022-11-21T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/OBD_logo-5JLe2M.jpeg https://medicaex.com/businesswire/teva-announces-appointment-of-richard-francis-as-president-and-ceo/ 2022-11-21T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Teva_CEO_Infographic_External-17REAm.jpeg https://medicaex.com/businesswire/merck-kgaa-darmstadt-germany-aims-to-double-rd-productivity-in-oncology-neurology-and-immunology-to-deliver-more-medicines-to-patients-faster/ 2022-11-21T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-8bpyg1.jpeg https://medicaex.com/businesswire/merck-aims-to-double-rd-productivity-in-oncology-neurology-and-immunology-to-deliver-more-medicines-to-patients-faster/ 2022-11-21T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/11127HIGH_MERCKLOGOBLUERGB-PROIMG-ahcyLu.jpeg https://medicaex.com/businesswire/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com-2/ 2022-11-21T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Fc6jVh.jpeg https://medicaex.com/businesswire/global-biodefense-market-report-to-2030-featuring-altimmune-emergent-biosolutions-siga-technologies-and-ichor-medical-systems-among-others-researchandmarkets-com/ 2022-11-21T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-g9qtCt.jpeg https://medicaex.com/businesswire/global-parkinsons-disease-treatment-market-report-2022-market-to-reach-6-7-billion-by-2027-levodopa-carbidopa-segment-is-projected-to-record-a-6-6-cagr-and-reach-2-4-billion-researchandmar/ 2022-11-21T11:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-2bp9j6.jpeg https://medicaex.com/businesswire/spectrumx-announces-appointment-of-new-regional-account-manager-uk-south-west-2/ 2022-11-21T10:12:07+00:00 https://medicaex.com/businesswire/the-worldwide-pharmacovigilance-drug-safety-software-industry-is-expected-to-reach-940-million-by-2027-researchandmarkets-com/ 2022-11-21T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-PDPKmq.jpeg https://medicaex.com/businesswire/insights-on-the-hemoglobinopathies-global-market-to-2031-increasing-prevalence-of-hemoglobinopathies-in-under-developed-and-developing-countries-is-driving-growth-researchandmarkets-com/ 2022-11-21T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jEwmHp.jpeg https://medicaex.com/businesswire/spectrumx-announces-appointment-of-new-regional-account-manager-uk-south-west/ 2022-11-21T10:12:03+00:00 https://medicaex.com/businesswire/ellipses-pharma-to-present-clinical-updates-at-leading-u-s-breast-and-blood-cancer-conferences-2/ 2022-11-21T09:12:08+00:00 https://medicaex.com/businesswire/ellipses-pharma-to-present-clinical-updates-at-leading-u-s-breast-and-blood-cancer-conferences/ 2022-11-21T09:12:04+00:00 https://medicaex.com/businesswire/ieso-awarded-most-transformative-digital-healthcare-company-at-the-2022-obn-awards-3/ 2022-11-21T08:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ieso_Green_RGB-ifvrAZ.jpeg https://medicaex.com/businesswire/ieso-awarded-most-transformative-digital-healthcare-company-at-the-2022-obn-awards-2/ 2022-11-21T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ieso_Green_RGB-RZMoze.jpeg https://medicaex.com/businesswire/ieso-awarded-most-transformative-digital-healthcare-company-at-the-2022-obn-awards/ 2022-11-21T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ieso_Green_RGB-zO7NWr.jpeg https://medicaex.com/businesswire/onward-awarded-european-innovation-council-grant-to-further-develop-brain-computer-interface-technology-company-also-wins-first-place-in-2022-brain-computer-interface-awards-2/ 2022-11-21T07:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-xCaeQV.jpeg https://medicaex.com/businesswire/onward-awarded-european-innovation-council-grant-to-further-develop-brain-computer-interface-technology-company-also-wins-first-place-in-2022-brain-computer-interface-awards/ 2022-11-21T07:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Onward-GD9OXf.jpeg https://medicaex.com/businesswire/elpiscience-announces-studies-presented-at-sitc-2022-annual-meeting-2/ 2022-11-21T03:12:26+00:00 https://medicaex.com/businesswire/elpiscience-announces-studies-presented-at-sitc-2022-annual-meeting/ 2022-11-21T03:12:06+00:00 https://medicaex.com/businesswire/shionogi-active-citizenship-network-and-meps-advocate-for-urgent-policy-implementation-in-eu-member-states-at-eu-parliament-event-to-address-the-growing-threat-of-antimicrobial-resistance-2/ 2022-11-21T00:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Shinogi_Logo-fE6vk9.jpeg https://medicaex.com/businesswire/shionogi-active-citizenship-network-and-meps-advocate-for-urgent-policy-implementation-in-eu-member-states-at-eu-parliament-event-to-address-the-growing-threat-of-antimicrobial-resistance/ 2022-11-21T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Shinogi_Logo-qfFEDL.jpeg https://medicaex.com/businesswire/gelesis-receives-notice-of-nyse-market-capitalization-listing-rule-non-compliance-2/ 2022-11-18T23:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gelesis_logo-GGrDy7.jpeg https://medicaex.com/businesswire/aptorum-group-limited-received-nasdaq-notification-letter-regarding-bid-price-deficiency-2/ 2022-11-18T23:12:07+00:00 https://medicaex.com/businesswire/aptorum-group-limited-received-nasdaq-notification-letter-regarding-bid-price-deficiency/ 2022-11-18T23:12:04+00:00 https://medicaex.com/businesswire/gelesis-receives-notice-of-nyse-market-capitalization-listing-rule-non-compliance/ 2022-11-18T23:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gelesis_logo-Y3fkz9.jpeg https://medicaex.com/businesswire/medx-announces-proposed-secured-convertible-debenture-financing-3/ 2022-11-18T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/MedX_Logo_copy-LEtAz8.jpeg https://medicaex.com/businesswire/wellbeing-digital-announces-resignation-of-directors/ 2022-11-18T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/61eb51c1cab991b7cbdd437e_Wellbeing_-_2col-oovmvv.jpeg https://medicaex.com/businesswire/medx-announces-proposed-secured-convertible-debenture-financing-2/ 2022-11-18T22:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/MedX_Logo_copy-2umQtj.jpeg https://medicaex.com/businesswire/medx-announces-proposed-secured-convertible-debenture-financing/ 2022-11-18T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/MedX_Logo_copy-NfWccA.jpeg https://medicaex.com/businesswire/global-cell-culture-market-2022-2028-steady-increase-in-demand-for-monoclonal-antibodies-rising-preference-for-single-use-technologies-and-increasing-rd-in-cell-based-research-drive-growth-r-2/ 2022-11-18T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MBJh7c.jpeg https://medicaex.com/businesswire/the-native-antigen-company-introduces-new-range-of-influenza-antigens-2/ 2022-11-18T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo_V1_2800229-Ff3EFS.jpeg https://medicaex.com/businesswire/2-day-life-sciences-good-manufacturing-practices-gmp-training-course-december-15-16-2022-researchandmarkets-com/ 2022-11-18T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bFaLlX.jpeg https://medicaex.com/businesswire/global-cell-culture-market-2022-2028-steady-increase-in-demand-for-monoclonal-antibodies-rising-preference-for-single-use-technologies-and-increasing-rd-in-cell-based-research-drive-growth-r/ 2022-11-18T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-EgLLVF.jpeg https://medicaex.com/businesswire/the-native-antigen-company-introduces-new-range-of-influenza-antigens/ 2022-11-18T18:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo_V1_2800229-aEa9I3.jpeg https://medicaex.com/businesswire/lysogene-provides-updates-and-topline-results-from-phase-2-3-aavance-gene-therapy-clinical-study-2/ 2022-11-18T17:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lysogene_-_Logo-FRSSA9.jpeg